Skip to content

Home
Insights
Brochures
Careers
About us
News

Home
Insights
Brochures
Careers
About us
News

Pharma News

Highlights from the week of 4th May - 11th May Lannett ( FDA, Approval ) FDA approves Lanex Biologics’ subsidiary Lannett and Sunshine Lake Pharma's interchangeable biosimilar, LANGLARA, to treat adult and pediatric patients with type 1 diabetes mellitus and adults with type 2 diabetes mellitus Bristol Myers Squibb ( EU, Approval ) EC grants approval to Bristol Myers Squibb's SOTYKTU, a once-daily, oral, selective TYK2 inhibitor to treat active PsA in adults with inadequate or intolerant response to DMARD therapy Biocon ( Health Canada, Approval ) Biocon gets Health Canada approval for its micafungin injection, USP, 50 mg and 100 mg for the treatment and as a prophylaxis of various Candida infections in patients undergoing hematopoietic stem cell transplantation Merck ( Acquisition ) Merck acquires Terns Pharmaceuticals along with its Breakthrough Therapy Designation drug TERN-701, a potential treatment option for certain patients with chronic myeloid leukemia All logos and trademarks remain the intellectual properties of their respective owners

Highlights from the Week of 04th May – 11th May in the world of pharma and healthcare!

May 11, 2026

Highlights from the Week of 27th April 2026 - 4th May 2026 ( FDA, Approval ) AstraZeneca's fixed-dose triple-combination therapy, BREZTRI AEROSPHERE, gains FDA approval for the maintenance treatment of asthma in patients aged 12 and older ( FDA, Approval ) Arvinas' VEPPANU receives FDA approval as the first-ever PROTAC therapy for the treatment of adults with ER+ or HER2- or ESR1 mutated, advanced or metastatic breast cancer ( FDA, Approval ) FDA approves Incyte's JAKAFI XR extended-release tablets to treat adults with intermediate- or high-risk myelofibrosis, polycythemia vera and adults or children who are 12 years and older with GVHD ( FDA, Approval ) Axsome secures approval from the FDA for its AUVELITY, targeting NMDA and sigma-1 receptors to treat dementia due to Alzheimer's disease Pg 1/3 All logos and trademarks remain the intellectual properties of their respective owners

Highlights from the Week of 27th April 2026 – 4th May 2026 in the world of pharma and healthcare!

May 5, 2026

Highlights from the Week of 20th April - 27th April FDA approves Sanofi's TZIELD sBLA to delay the onset of stage 3 type 1 diabetes in young children AstraZeneca's SAPHNELO Pen for self-administration gets FDA approval for the treatment of adult patients with SLE on top of standard therapy Regeneron receives accelerated approval from FDA for OTARMENI to treat patients with severe-to-profound and profound sensorineural hearing loss ( FDA, Accelerated Approval ) ( FDA, Approval ) ( FDA, Approval ) Pg 1/6 All logos and trademarks remain the intellectual properties of their respective owners

Highlights from the Week of 20th April – 27th April in the world of pharma and healthcare!

April 28, 2026

« Previous Page1 Page2 Page3 Page4 Page5 Next »

Investor calendar

Bank of America Securities Healthcare Conference May 12,2026 To May 14,2026 May 12 May 13 May 14 All logos and trademarks remain the intellectual properties of their respective owners

Attention stay up to date with the latest investor calls by checking out our calendar for the week of May 12,2026 To May 14,2026

May 11, 2026

Q1 2026 Earning Conference Call May 04,2026 To May 07,2026 May 04 May 05 May 07 All logos and trademarks remain the intellectual properties of their respective owners

Attention stay up to date with the latest investor calls by checking out our calendar for the week of May 04,2026 To May 07,2026

May 5, 2026

Q1 2026 Earnings Call Apr 28,2026 To Apr 30,2026 April 28 April 29 April 30 All logos and trademarks remain the intellectual properties of their respective owners

Attention stay up to date with the latest investor calls by checking out our calendar for the week of April 28,2026 To April 30,2026

April 28, 2026

« Previous Page1 Page2 Page3 Page4 Page5 Next »

Healthcare Insights

High blood pressure isn’t just a clinical issue; it’s a productivity and workplace wellness issue. Given that stress is a major contributor to hypertension, the 2026 theme “Controlling Hypertension Together” hits home for leadership teams everywhere. Let’s foster environments where health is as important as the bottom line. 📈❤️

May 17, 2026

On World Lupus Day, we stand in support of everyone affected by lupus — raising awareness, encouraging early diagnosis, and advocating for better care and research. 💜Together, we can help improve lives through awareness, innovation, and compassion.

May 10, 2026

WORLD THALASSEMIA DAY HIDDEN NO MORE - Finding the Undiagnosed, Supporting the Unseen AN INHERITED HEMOGLOBIN DISORDER Thalassemia is a genetic condition caused by mutations in globin genes that lead to an imbalance of α- and β-globin chains, resulting in red blood cell destruction The 2026 Global Mission: To identify undiagnosed individuals and support those whose daily challenges remain unrecognized by society & healthcare systems Global Lighting Initiative "Bring To Light" movement encourages cities to illuminate iconic landmarks in red to symbolize solidarity and advocacy Alpha vs. Beta Thalassemia PREVALENCE Alpha Beta Alpha types involves deletions on chromosome 16 Beta types usually involve point mutations on chromosome 11 Minor vs. Major (TDT vs. NTDT) 1.3 M Global Cases Among them, 400,000 children are born with severe forms annually Mild Severe Minor/Trait Major/Transfusion-Dependent Often asymptomatic carriers Requires lifelong blood support for survival THALASSEMIA BELT REGIONS SYMPTOMS & COMPLICATIONS Chronic fatigue Pale skin Jaundice Shortness of breath Bone deformities Growth retardation THE TREATMENT REVOLUTION CASGEVY REBLOZYL Cell-based gene therapy Erythroid maturation agent The Danger of Iron Overload STANDARD CARE: TRANSFUSIONS & CHELATION Frequent transfusions can lead to iron accumulation, causing and organ damage Regular blood transfusions to maintain hemoglobin levels and iron chelation therapy to remove excess iron from the body Vyuhpharma® All Rights Reserved Note: This report is generated based on publicly available data

Every drop of awareness brings hope ❤️On World Thalassemia Day, we work together to create awareness on thalassemia, encourage early diagnosis and better access to care, and support patients and their families Together, we can help build a healthier and stronger future for every life affected by thalassemia

May 8, 2026

« Previous Page1 Page2 Page3 Next »

The Pharma BI division of

Vyuhgenics Inc.

Henderson, Nevada, USA – 89014

Vyuhpharma ®, All Rights Reserved.

Sitemap

Terms of use

Connect with us

Please fill in the information below, and we'll get back to you.

Full Name

Email Address

Your Company

Contact

Your message